PRME News and Press, First Trust Heitman Global Prime Real Estate ETF From 01/25/24

CAMBRIDGE, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that the Cystic Fibrosis Foundation (CF Foundation) has agreed to provide the...

2024-01-16 15:41:17 ET More on Prime Medicine Prime Medicine GAAP EPS of -$0.55 misses by $0.07 Gene editing stocks gain after Eli Lilly deal amid FDA AdCom Seeking Alpha’s Quant Rating on Prime Medicine Historical earnings data for Prime Medicine ...

2024-01-10 19:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-05 17:10:32 ET More on Prime Medicine Prime Medicine GAAP EPS of -$0.55 misses by $0.07 Gene editing stocks gain after Eli Lilly deal amid FDA AdCom For further details see: Prime Medicine and Myeloid Therapeutics resolve all pending disputes

2024-01-05 08:29:06 ET More on Prime Medicine Prime Medicine GAAP EPS of -$0.55 misses by $0.07 Gene editing stocks gain after Eli Lilly deal amid FDA AdCom Seeking Alpha’s Quant Rating on Prime Medicine Historical earnings data for Prime Medicine ...

CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Allan Reine, M.D., as the Company’s Chief Financial...

CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime...

2023-12-22 23:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-19 10:30:00 ET Small-cap stocks are often attractive investments in bullish markets. While a bull market is not guaranteed in 2024, some small caps are already heating up in anticipation of better economic conditions next year. As a result, it might be a smart move to start adding s...

2023-12-01 14:45:50 ET Summary AI isn't just revolutionizing biotech; it's reinventing it. From predicting diseases to accelerating drug discovery, AI is turning data into medical gold, reshaping how we approach healthcare innovation. AI is turbocharging techniques like CRISPR and...